MedTech News
.................... by Andrew Celentano
Genome-edited stem cells dodge antibodies, raising hope for chemo-free transplants
Stem cell transplantation (also called bone marrow transplantation) and gene therapy are among the most powerful curative approaches for blood diseases such as sickle cell disease, b-thalassemia, immune deficiencies and some blood cancers.
Presage Technologies Earns FDA Clearance for Contactless Vital Signs, Makes Them Available for Free
FDA-cleared camera-based vital signs platform offers heart rate and breathing rate at no cost to hospitals, clinics, health organizations, and educators.
Vera moves into growing kidney disease space with FDA’s accelerated IgAN nod
Vera Therapeutics’ atacicept, to be marketed as Trutakna, will go up against Novartis, Otsuka and possibly Vertex in the kidney disease primary IgA nephropathy after receiving an accelerated FDA approval.
Beckman Coulter’s Alzheimer’s blood test obtains CE mark
Beckman Coulter’s assay is used to measure phosphorylated tau (pTau217) levels in the blood of individuals displaying signs of cognitive decline.
Medicaroid wins CE mark for surgical robot
Japanese medtech company Medicaroid announced today that it received CE mark approval for its Hinotori surgical robot system.
Electric fields could organize neural activity trial by trial during memory tasks
It’s a fact of life that the electrical activity of neurons will vary during the same task, even when the ultimate outcome is the same.
A new “tumor-on-a-chip” model is giving scientists a live look at how pancreatic cancer can recruit the body’s own immune cells to help tumors survive.
A new “tumor-on-a-chip” model is giving scientists a live look at how pancreatic cancer can recruit the body’s own immune cells to help tumors survive.
Study linking microgravity and space radiation to accelerated aging could yield therapies on Earth
What happens to the human body in space may help scientists create new anti-aging therapies.